CSIMarket
 
Astria Therapeutics inc   (ATXS)
Other Ticker:  
 
 

Astria Therapeutics Inc's Suppliers Performance

ATXS's Supply Chain

 
ATXS Costs vs Sales of Suppliers Growth

More on ATXS Suppliers






  News about Astria Therapeutics inc Contracts

Preclinical Evaluation of STAR-0310: A Promising Therapy for Allergic and Immunological Dermatological Conditions

Abstract:This article provides a comprehensive overview of the preclinical profile of STAR-0310, a novel therapeutic candidate developed by Astria Therapeutics for the treatment of allergic and immunological dermatological diseases. The preclinical data was presented at the Society for Investigative Dermatology Annual Meeting, highlighting the potential of STAR-0310 in transforming the lives of patients suffering from these debilitating conditions. Dr. Chunxia Lily Zhao, Director of Antibody Discovery at Astria Therapeutics, presented the findings and discussed the therapeutic benefits and mechanism of action of STAR-0310.Allergic and immunological dermatological diseases pose significant challenges to patie...




Astria Therapeutics Inc's Comment on Supply Chain









ATXS's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Astria Therapeutics inc 501.51 0.00 -81.63 10
SUBTOTAL 0.00 0.00 0.00 -


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com